Literature DB >> 27573733

High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.

Mariko Tani1, Katalin V Horvath1, Benoit Lamarche2, Patrick Couture2, John R Burnett3, Ernst J Schaefer1, Bela F Asztalos4.   

Abstract

BACKGROUND AND AIMS: Our aim was to gain insight into the role that lipoprotein lipase (LPL) and hepatic lipase (HL) plays in HDL metabolism and to better understand LPL- and HL-deficiency states.
METHODS: We examined the apolipoprotein (apo) A-I-, A-II-, A-IV-, C-I-, C-III-, and E-containing HDL subpopulation profiles, assessed by native 2-dimensional gel-electrophoresis and immunoblotting, in 6 homozygous and 11 heterozygous LPL-deficient, 6 homozygous and 4 heterozygous HL-deficient, and 50 control subjects.
RESULTS: LPL-deficient homozygotes had marked hypertriglyceridemia and significant decreases in LDL-C, HDL-C, and apoA-I. Their apoA-I-containing HDL subpopulation profile was shifted toward small HDL particles compared to controls. HL-deficient homozygotes had moderate hypertriglyceridemia, modest increases in LDL-C and HDL-C level, but normal apoA-I concentration. HL-deficient homozygotes had a unique distribution of apoA-I-containing HDL particles. The normally apoA-I:A-II, intermediate-size (α-2 and α-3) particles were significantly decreased, while the normally apoA-I only (very large α-1, small α-4, and very small preβ-1) particles were significantly elevated. In contrast to control subjects, the very large α-1 particles of HL-deficient homozygotes were enriched in apoA-II. Homozygous LPL- and HL-deficient subjects also had abnormal distributions of apo C-I, C-III, and E in HDL particles. Values for all measured parameters in LPL- and HL-deficient heterozygotes were closer to values measured in controls than in homozygotes.
CONCLUSIONS: Our data are consistent with the concept that LPL is important for the maturation of small discoidal HDL particles into large spherical HDL particles, while HL is important for HDL remodeling of very large HDL particles into intermediate-size HDL particles.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apolipoproteins; HDL particles; HDL remodeling; Lipoprotein metabolism; Reverse cholesterol transport

Mesh:

Substances:

Year:  2016        PMID: 27573733      PMCID: PMC5064856          DOI: 10.1016/j.atherosclerosis.2016.08.014

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  37 in total

1.  Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease.

Authors:  B F Asztalos; M E Brousseau; J R McNamara; K V Horvath; P S Roheim; E J Schaefer
Journal:  Atherosclerosis       Date:  2001-05       Impact factor: 5.162

2.  Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene.

Authors:  Jonas Peterson; Amir F Ayyobi; Yuanhong Ma; Howard Henderson; Manuel Reina; Samir S Deeb; Silvia Santamarina-Fojo; Michael R Hayden; John D Brunzell
Journal:  J Lipid Res       Date:  2002-03       Impact factor: 5.922

3.  Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.

Authors:  C M Ballantyne; J A Herd; L L Ferlic; J K Dunn; J A Farmer; P H Jones; J R Schein; A M Gotto
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

4.  Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

Authors:  Frank M Sacks; Lawrence L Rudel; Adam Conner; Hassibullah Akeefe; Gerhard Kostner; Talal Baki; George Rothblat; Margarita de la Llera-Moya; Bela Asztalos; Timothy Perlman; Chunyu Zheng; Petar Alaupovic; Jo-Ann B Maltais; H Bryan Brewer
Journal:  J Lipid Res       Date:  2009-01-14       Impact factor: 5.922

5.  Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics.

Authors:  R A Hegele; J A Little; C Vezina; G F Maguire; L Tu; T S Wolever; D J Jenkins; P W Connelly
Journal:  Arterioscler Thromb       Date:  1993-05

6.  The impact of partial and complete loss-of-function mutations in endothelial lipase on high-density lipoprotein levels and functionality in humans.

Authors:  Roshni R Singaraja; Suthesh Sivapalaratnam; Kees Hovingh; Marie-Pierre Dubé; José Castro-Perez; Heidi L Collins; Steven J Adelman; Meliana Riwanto; Jasmin Manz; Brian Hubbard; Ian Tietjen; Kenny Wong; Lyndon J Mitnaul; Margaret van Heek; Linus Lin; Thomas A Roddy; Jason McEwen; Geesje Dallinge-Thie; Leonie van Vark-van der Zee; Germaine Verwoert; Michael Winther; Cornelia van Duijn; Albert Hofman; Mieke D Trip; A David Marais; Bela Asztalos; Ulf Landmesser; Eric Sijbrands; John J Kastelein; Michael R Hayden
Journal:  Circ Cardiovasc Genet       Date:  2012-12-14

7.  Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency.

Authors:  Bela F Asztalos; Katalin V Horvath; Kouji Kajinami; Chorthip Nartsupha; Caitlin E Cox; Marcelo Batista; Ernst J Schaefer; Akihiro Inazu; Hiroshi Mabuchi
Journal:  J Lipid Res       Date:  2003-12-01       Impact factor: 5.922

8.  Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia.

Authors:  L A Carlson; L Holmquist; P Nilsson-Ehle
Journal:  Acta Med Scand       Date:  1986

9.  Characterization of a novel mutation causing hepatic lipase deficiency among French Canadians.

Authors:  Isabelle L Ruel; Patrick Couture; Claude Gagne; Yves Deshaies; Jacques Simard; Robert A Hegele; Benoît Lamarche
Journal:  J Lipid Res       Date:  2003-06-01       Impact factor: 5.922

10.  Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.

Authors:  Carlos O Mendivil; Jeremy Furtado; Allyson M Morton; Liyun Wang; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-05       Impact factor: 8.311

View more
  7 in total

1.  Influence of HDL particles on cell-cholesterol efflux under various pathological conditions.

Authors:  Bela F Asztalos; Katalin V Horvath; Michael Mehan; Yuya Yokota; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2017-04-18       Impact factor: 5.922

Review 2.  Successful Genetic Screening and Creating Awareness of Familial Hypercholesterolemia and Other Heritable Dyslipidemias in the Netherlands.

Authors:  Linda C Zuurbier; Joep C Defesche; Albert Wiegman
Journal:  Genes (Basel)       Date:  2021-07-29       Impact factor: 4.096

3.  High-Density Lipoprotein Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk.

Authors:  Bela F Asztalos; Katalin V Horvath; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

4.  Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients.

Authors:  Ines Potočnjak; Matias Trbušić; Sanda Dokoza Terešak; Bojana Radulović; Gudrun Pregartner; Andrea Berghold; Beate Tiran; Gunther Marsche; Vesna Degoricija; Saša Frank
Journal:  Sci Rep       Date:  2017-04-26       Impact factor: 4.379

5.  Endothelial lipase increases antioxidative capacity of high-density lipoprotein.

Authors:  Irene Schilcher; Gerhard Ledinski; Snježana Radulović; Seth Hallström; Thomas Eichmann; Tobias Madl; Fangrong Zhang; Gerd Leitinger; Dagmar Kolb-Lenz; Barbara Darnhofer; Ruth Birner-Gruenberger; Christian Wadsack; Dagmar Kratky; Gunther Marsche; Saša Frank; Gerhard Cvirn
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-06-17       Impact factor: 4.698

6.  The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes.

Authors:  Jonathan M Wilson; Amir Nikooienejad; Deborah A Robins; William C Roell; Jeffrey S Riesmeyer; Axel Haupt; Kevin L Duffin; Marja-Riitta Taskinen; Giacomo Ruotolo
Journal:  Diabetes Obes Metab       Date:  2020-09-15       Impact factor: 6.577

7.  Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry.

Authors:  Zsuzsanna Kuklenyik; Jeffery I Jones; Michael S Gardner; David M Schieltz; Bryan A Parks; Christopher A Toth; Jon C Rees; Michael L Andrews; Kayla Carter; Antony K Lehtikoski; Lisa G McWilliams; Yulanda M Williamson; Kevin P Bierbaum; James L Pirkle; John R Barr
Journal:  PLoS One       Date:  2018-04-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.